Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy

The transverse relaxation time of water protons is shortened by the presence of iron. This shortening depends on the amount and the environment of iron in the sample. We have developed a method for measuring short transverse relaxation time noninvasively by magnetic resonance spectroscopy. To evaluate magnetic resonance spectroscopy as a means of assessing hepatic iron content in patients with transfusional iron overload, we compared the results obtained with this method with those obtained by other means of assessing total body iron content. The correlation between the liver biopsy iron concentration and 1/transverse relaxation time was highly significant (r = 0.95, p < 0.004, n = 6) for iron loads up to 3% dry weight. The correlation between serum ferritin and 1/transverse relaxation time was also significant, but the correlation coefficient was much lower (r = 0.67, p < 0.002, n = 20). The correlation between 24‐hr urinary iron excretion and 1/transverse relaxation time was not significant, nor was that between AST and 1/transverse relaxation time. We conclude that magnetic resonance spectroscopic determination of the transverse relaxation time of hepatic water is an accurate method of measuring liver iron content, especially when the iron content is below 3%. Because it is a noninvasive method that is associated with negligible side effects, it could provide clinicians with an excellent means of assessing the effectiveness of the various therapeutic strategies used in the management of patients with iron overload. (HEPATOLOGY 1994;19:904–910.)

[1]  P. Styles,et al.  An assessment of spin‐echo rotating‐frame imaging for spatially localized determination of short T2 relaxation times in vivo , 1993, Magnetic resonance in medicine.

[2]  A. Hoffbrand,et al.  Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. , 1992, Blood.

[3]  C. Jacquelinet,et al.  Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. , 1992, Journal of hepatology.

[4]  D. Caramella,et al.  Assessment of Liver Iron Overload in Thalassemic Patients by Mr Imaging , 1992, Acta radiologica.

[5]  M. Harada,et al.  Comparative study of magnetic resonance imaging, computed tomography and histology in the assessment of liver iron overload. , 1992, Internal medicine.

[6]  J. Gomori,et al.  Hepatic iron overload: quantitative MR imaging. , 1991, Radiology.

[7]  D. Mitchell,et al.  Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. , 1991, Radiology.

[8]  K. Ehlers,et al.  Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. , 1991, The Journal of pediatrics.

[9]  H. Bonkovsky,et al.  Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. , 1990, Gastroenterology.

[10]  R. Hultcrantz,et al.  Liver cell damage and lysosomal iron storage in patients with idiopathic hemochromatosis. A light and electron microscopic study. , 1990, Journal of hepatology.

[11]  A. Hoffbrand,et al.  Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. , 1990, Journal of clinical pathology.

[12]  R. Gottschalk,et al.  Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging , 1990, British journal of haematology.

[13]  M. Simon,et al.  Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. , 1989, Gastroenterology.

[14]  A. Piga,et al.  SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR , 1989, The Lancet.

[15]  P. Styles,et al.  Passive electrical isolation of double coil probes for localized spectroscopy and imaging , 1988, NMR in biomedicine.

[16]  A. Hoffbrand,et al.  Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. , 1987, Journal of clinical pathology.

[17]  S. H. Koenig,et al.  Transverse relaxation of solvent protons induced by magnetized spheres: Application to ferritin, erythrocytes, and magnetite , 1987, Magnetic resonance in medicine.

[18]  G. Radda,et al.  Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Cook,et al.  A serum ferritin assay for prevalence studies of iron deficiency , 1986, American journal of hematology.

[20]  S. H. Koenig,et al.  Relaxometry of ferritin solutions and the influence of the Fe3+ core ions , 1986, Magnetic resonance in medicine.

[21]  I. Cavill,et al.  Diagnostic Methods for Iron Status , 1986, Annals of clinical biochemistry.

[22]  M. Weiner,et al.  Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective. , 1978, The Journal of pediatrics.

[23]  T. Dormandy,et al.  Serum copper and related variables in rheumatoid arthritis. , 1978, Annals of the rheumatic diseases.

[24]  P. Harrison,et al.  The structure and function of ferritin. , 1976, Ciba Foundation symposium.

[25]  M. Becker,et al.  HYPERTRANSFUSION REGIMEN IN PATIENTS WITH Cooley's ANEMIA * , 1974, Annals of the New York Academy of Sciences.

[26]  S. Sherlock,et al.  Measurement of liver-iron concentration in needle-biopsy specimens. , 1971, Lancet.

[27]  I. Wolman,et al.  SOME CLINICAL FEATURES OF COOLEY'S ANEMIA PATIENTS AS RELATED TO TRANSFUSION SCHEDULES , 1969, Annals of the New York Academy of Sciences.

[28]  G. Whipple,et al.  Mediterranean disease-thalassemia(Erythroblastic anemia of cooley) , 1936 .

[29]  M. Moseley,et al.  Magnetic resonance imaging and spectroscopy of hepatic iron overload. , 1985, Radiology.

[30]  M. Greenberg Letter: Haemophilia in women. , 1974, Lancet.